MeiraGTx (MGTX) stock jumps as the company plans to disclose long-term data from a Phase 1 trial for its gene therapy ...

Presentation to include 3-year data from all cohorts of the Phase 1 AQUAx Clinical Study- Cohort-level data and individual patient data from ...

Modern medicine is one of the reasons we’re able to take care of ourselves, stay healthy, and recover from illnesses that ...

While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that ...

TORONTO — Cancer experts say a new study highlights the need for more support and screening of people who survived cancer as ...

The Alliance for Clinical Trials in Oncology is now enrolling patients into a clinical trial aimed at helping women recover ...

FDA acceptance positions 18F-FET as a potential first-in-class US-approved amino acid PET agent for glioma characterization, addressing a major posttreatment imaging specificity gap.

Lumonus, developers of Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, have formed a strategic collaboration with Memorial Sloan Kettering Cancer ...

NAPT recognized Dr. Frank at the 2026 NPC with its Accelerator Award for Clinical Achievement, honoring exceptional clinicians who demonstrate leadership in proton therapy and play a pivotal role in ...

Modern techniques have greatly reduced the heart disease risks historically tied to radiotherapy for left-sided breast cancer, a large cohort study suggests.

Investigators sought to determine whether left-sided EBRT has different long-term cardiotoxicity risks than right-sided EBRT among women with breast cancer.

In a preclinical study published in Cancer Research, researchers from the University of Texas MD Anderson Cancer Center have ...